Asthma control and exacerbations in patients with severe asthma treated with omalizumab in Portugal

A.S.. Sousaa, A.M.. Pereirab,c,d, J.A.. Fonsecaa,

,c,d, L.F.. Azevedoa,d, C.. Abreue, A.. Arrobasf, T.. Calvog, M.J.. Silvestreg, L.. Cunhah, H.. Falcãoh, M.. Drummondi, L.. Geraldesj, C.. Loureirok

a Center for Research in Health Technologies and Information Systems, Faculdade de Medicina da Universidade do Porto, Porto, Portugal

b Allergy Department, Centro Hospitalar de São João, EPE, Porto, Portugal

c Allergy Unit, CUF Porto Instituto e CUF Porto Hospital, Portugal

d Health Information and Decision Sciences Department, Faculdade de Medicina da Universidade do Porto, Porto, Portugal

e Allergy Department, Hospital Pedro Hispano Unidade Local de Saúde de Matosinhos, EPE, Matosinhos, Portugal

f Pulmonology Department, Hospital Geral de Coimbra Centro Hospitalar e Universitário de Coimbra, EPE, Coimbra, Portugal

g Pulmonology Department, Centro Hospitalar de Trás os Montes e Alto Douro, EPE, Vila Real, Portugal

h Allergy Department, Centro Hospitalar do Porto, EPE, Porto, Portugal

i Pulmonology Department, Centro Hospitalar de São João, EPE, Porto, Portugal

j Allergy Department, Centro Hospitalar do Alto Ave, EPE, Guimarães, Portugal

k Pulmonology Department, Centro Hospitalar e Universitário de Coimbra, EPE, Coimbra, Portugal

Read

12168

Times
was read the article

3093

Total PDF

9075

Total HTML

Share statistics

Article information

ISSN: 08732159
Original language: English

The statistics are updated each day

Year/Month	Html	Pdf	Total

2025 6	17	2	19
2025 5	145	48	193
2025 4	96	42	138
2025 3	100	40	140
2025 2	72	38	110
2025 1	69	45	114
2024 12	58	35	93
2024 11	78	58	136
2024 10	63	42	105
2024 9	61	34	95
2024 8	79	47	126
2024 7	85	33	118
2024 6	82	40	122
2024 5	91	50	141
2024 4	71	37	108
2024 3	70	35	105
2024 2	49	31	80
2024 1	44	32	76
2023 12	46	22	68
2023 11	51	38	89
2023 10	61	38	99
2023 9	50	37	87
2023 8	66	20	86
2023 7	46	31	77
2023 6	67	17	84
2023 5	77	39	116
2023 4	59	22	81
2023 3	111	17	128
2023 2	84	25	109
2023 1	35	22	57
2022 12	71	15	86
2022 11	72	43	115
2022 10	66	29	95
2022 9	43	31	74
2022 8	50	37	87
2022 7	37	55	92
2022 6	41	28	69
2022 5	46	51	97
2022 4	53	44	97
2022 3	51	68	119
2022 2	40	44	84
2022 1	45	34	79
2021 12	43	38	81
2021 11	51	40	91
2021 10	47	44	91
2021 9	43	25	68
2021 8	33	23	56
2021 7	29	21	50
2021 6	41	25	66
2021 5	51	21	72
2021 4	145	68	213
2021 3	43	17	60
2021 2	48	15	63
2021 1	42	15	57
2020 12	47	14	61
2020 11	50	17	67
2020 10	44	28	72
2020 9	61	21	82
2020 8	90	30	120
2020 7	102	18	120
2020 6	101	24	125
2020 5	101	14	115
2020 4	102	9	111
2020 3	85	13	98
2020 2	109	31	140
2020 1	109	12	121
2019 12	103	23	126
2019 11	90	25	115
2019 10	92	20	112
2019 9	105	22	127
2019 8	333	23	356
2019 7	388	14	402
2019 6	414	11	425
2019 5	348	20	368
2019 4	340	34	374
2019 3	430	16	446
2019 2	402	5	407
2019 1	212	21	233
2018 12	114	8	122
2018 11	89	3	92
2018 10	119	8	127
2018 9	29	9	38
2018 8	39	21	60
2018 7	61	15	76
2018 6	68	15	83
2018 5	114	18	132
2018 4	85	22	107
2018 3	49	26	75
2018 2	30	10	40
2018 1	20	18	38
2017 12	29	20	49
2017 11	23	10	33
2017 10	22	19	41
2017 9	19	13	32
2017 8	22	21	43
2017 7	22	15	37
2017 6	14	13	27
2017 5	19	19	38
2017 4	10	4	14
2017 3	12	8	20
2017 2	8	6	14
2017 1	22	12	34
2016 12	21	8	29
2016 11	18	9	27
2016 10	39	8	47
2016 9	16	12	28
2016 8	25	22	47
2016 7	28	54	82
2016 6	1	99	100
2016 5	0	11	11
2016 4	22	1	23
2016 3	27	27	54
2016 2	88	54	142
2016 1	91	62	153
2015 12	88	80	168

Show all

Statistics